Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesAnakinra in the treatment of rheumatoid arthritis and other IL-1-driven conditions
Future Rheumatology, 10/02/07
Nordstrom, D.C., et al. - Fewer than 40% of newly diagnosed patients with rheumatoid arthritis (RA) reach remission with a combination of traditional DMARDs, and therefore new effective therapies are still needed. Proinflammatory cytokines, such as TNF-alpha and IL-1, are important pathogenetic mediators in RA and related conditions. Targeted therapies against these cytokines and downstream inflammatory mediators have greatly added to the therapeutic arsenal and brought new hope to patients in providing physicians with new effective treatment options
Related Articles
Treatment of early RA with infliximab is beneficial
American Pharmacists Association, 11/06/09
Relevance Score: 90%
Update on the Management of Pain in Arthritis and the Use of Cyclooxygenase-2 Inhibitors
Current Pain and Headache Reports, 11/06/09
Relevance Score: 90%
The effects of adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients
Rheumatology International, 10/28/09
Relevance Score: 90%
Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial
Clinical Therapeutics, 10/15/09
Relevance Score: 90%
Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in one rheumatological center: two years drug survival
Rheumatology International, 10/14/09
Relevance Score: 90%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients
Scandinavian Journal of Pain, 12/04/09
Role and place of methotrexate in vasculitis management
International Journal of Clinical Rheumatology, 12/04/09
The Statin Choice decision aid in primary care: A randomized trial
Patient Education and Counselling, 12/04/09
Today in Orthopedic/Physical Med...keeping you current
Receive free subspecialty "5-minute updates" via email
Ultrasound evidence of altered lumbar connective tissue structure in human subjects with chronic low back pain
BMC Musculoskeletal Disorders, 12/03/09
Some Factors Predict Successful Short-Term Outcomes in Individuals With Shoulder Pain Receiving Cervicothoracic Manipulation: A Single-Arm Trial
Physical Therapy, 12/03/09
Vitamin K2 supplementation does not influence bone loss in early menopausal women: A randomised double-blind placebo-controlled trial
Osteoporosis International, 12/03/09
Today in Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Denuded subchondral bone and knee pain in persons with knee osteoarthritis
Arthritis & Rheumatism, 12/04/09
Role and place of methotrexate in vasculitis management
International Journal of Clinical Rheumatology, 12/04/09
Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis
European Journal of Clinical Investigation, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor